Synapse - William Tap

Search Within

William Douglas Tap

Results (375)

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses

Journal Article

Seligson, N. D.; Chen, J. L.; Goodrich, A. C.; Van Tine, B. A.; Campbell, J. D.; Richards, A. L.; Antonescu, C. R.; Liebner, D. A.; Milhem, M. M.; Streicher, H.; more...
Journal for ImmunoTherapy of Cancer (2024)

Fulltext@MSK | Save

The impact of Li-Fraumeni and germline retinoblastoma mutations on leiomyosarcoma initiation, outcomes, and genetic testing recommendations

Journal Article

Dermawan, J. K.; Abramson, D. H.; Chiang, S.; Hensley, M. L.; Tap, W. D.; Movva, S.; Maki, R. G.; Mandelker, D.; Antonescu, C. R.
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Peak study: A phase 3, randomized, open-label multicenter clinical study of bezuclastinib (CGT9486) and sunitinib in combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)

Meeting Abstract

Heinrich, M. C.; Somaiah, N.; Trent, J. C.; Wilky, B. A.; Burgess, M. A.; Singh, A. S.; Attia, S.; Agulnik, M.; Tap, W. D.; Bauer, S.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

A multimodal neural network with gradient blending improves predictions of survival and metastasis in sarcoma

Journal Article

Bozzo, A.; Hollingsworth, A.; Chatterjee, S.; Apte, A.; Deng, J.; Sun, S.; Tap, W.; Aoude, A.; Bhatnagar, S.; Healey, J. H.
npj Precision Oncology (2024)

Fulltext@MSK | Save

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: Retrospective study from the Ultra-Rare Sarcoma Working Group

Journal Article

Giani, C.; Denu, R. A.; Ljevar, S.; Gronchi, A.; Napolitano, A.; Rosenbaum, E.; Salawu, A.; Bajpai, J.; Connolly, E. A.; Lee, A. T. J.; more...
ESMO Open (2024)

Fulltext@MSK | Save

CSF1R inhibition in patients with advanced solid tumors or tenosynovial giant cell tumor: A phase I study of vimseltinib

Journal Article

Gelderblom, H.; Razak, A. A.; Taylor, M. H.; Bauer, T. M.; Wilky, B.; Martin-Broto, J.; Gonzalez, A. F.; Rutkowski, P.; Szostakowski, B.; Alcindor, T.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Real-world experience of patients newly initiated on pexidartinib for tenosynovial giant cell tumor

Meeting Abstract

Dai, D.; Tecson, K.; Pan; Ye, X.; Tap, W. D.
Value in Health (2024)

Fulltext@MSK | Save

Health-related quality of life from a phase 4 global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor (TGCT) previously treated with pexidartinib

Meeting Abstract

Desai, J.; Wagner, A. J.; Garcia, I. C.; Cesari, M.; Gordon, M.; Lin, C. C.; Papai, Z.; Ryan, C. W.; Tap, W. D.; Trent, J. C.; more...
Value in Health (2024)

Fulltext@MSK | Save

Peak study: A phase 3, randomized, open-label multi-center clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)

Meeting Abstract

Tap, W. D.; Somaiah, N.; Kang, Y. K.; Ryan, A.; Razak, A.; Garrido, M.; Desar, I. M. E.; Italiano, A.; Reichardt, P.; Wilky, B. A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial

Meeting Abstract

Tap, W. D.; Bhadri, V.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; de Sande, M. V.; Bernthal, N. M.; Pousa, A. L.; Razak, A. R. A.; Italiano, A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save